Plamen Mihaylov

Plamen Mihaylov

Auto-generated profile, based on publicly available information

Plamen Mihaylov

Division of Transplantation, Indiana University, Indianapolis, Indiana

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2023 in American Journal of Transplantation
Verified
Journal Article
Open access
SSSerkan Sucu
Serkan Sucu
KBKerem E. Basarir
Kerem E. Basarir
PMPlamen Mihaylov
Plamen Mihaylov
EBEmre BALIK
Emre BALIK
JLJason T.C. Lee
Jason T.C. Lee
BEBurcin Ekser
Burcin Ekser
The gut microbiota has been gaining attention due to its interactions with the human body and its role in pathophysiological processes. One of the main interactions is the "gut-liver axis", in which disruption of the gut mucosal barrier seen in portal hypertension and liver disease can influence liver allograft function over time. For example, in patients who are undergoing liver transplantation, preexisting dysbiosis, perioperative antibiotic use, surgical stress, and immunosuppressive use have each been associated with alterations in gut microbiota, potentially impacting overall morbidity and mortality. In this review, studies exploring gut microbiota changes in patients undergoing liver transplantation are reviewed, including both human and experimental animal studies. Common themes include an increase in Enterobacteriaceae and Enterococcaceae species and a decrease in Faecalibacterium prausnitzii and Bacteriodes, while a decrease in the overall diversity of gut microbiota following liver transplantation.

1 January 2008 in World Journal of Gastroenterology
Verified
Journal Article
Open access
Paolo AseniPaolo Aseni
Paolo Aseni
SSStefano Di Sandro
Stefano Di Sandro
PMPlamen Mihaylov
Plamen Mihaylov
LLLuca Lamperti
Luca Lamperti
LCLuciano Gregorio De Carlis
Luciano Gregorio De Carlis
Atypical presentation of pioderma gangrenosum complicating ulcerative colitis: Rapid disappearance with methylprednisolone

16 July 2019 in Annals of Transplantation
Verified
Journal Article
Open access
PMPlamen Mihaylov
Plamen Mihaylov
SNShunji Nagai
Shunji Nagai
BEBurcin Ekser
Burcin Ekser
RMRichard Mangus
Richard Mangus
JFJonathan Fridell
Jonathan Fridell
CKChandrashekhar Kubal
Chandrashekhar Kubal
BACKGROUND Serum sodium (Na) is considered to reflect the severity of liver cirrhosis. In the last few years, much effort has been made to integrate this association into prognostic models after liver transplantation. The aim of this study was to investigate the associations between peritransplant Na and neurological complications, as well as short-term survival, after liver transplantation. MATERIAL AND METHODS A total of 306 liver transplantations between 2012 and 2015 were evaluated. Pre- and posttransplant sodium concentrations were investigated with regard to 3-month survival and incidence of posttransplant neurological complications, along with other factors present in the operative side of the recipient and donor. RESULTS The 3-month survival rate was 94%. Neither hyponatremia (145 mEq/L) at pretransplantion predicted 3-month survival. A large amount of intraoperative blood transfusion and a large delta Na showed a significant association with poor outcomes at 3 months. On multivariate analysis, the requirement of blood transfusion and warm ischemia time remained independent prognostic factors for 3-month mortality. Hyponatremia and a large delta Na tended to lead to the frequent development of neurological complications. These complications, secondary to rapid Na correction, were concerning and potentially led to a prolonged hospital stay and early mortality. CONCLUSIONS Rapid change in the sodium level might be caused by large amounts of blood transfusion products. This leads to a diminished short-term survival, as well as a higher rate of neurological complications.

25 March 2021 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
CKChandrashekhar A Kubal
Chandrashekhar A Kubal
PMPlamen Mihaylov
Plamen Mihaylov
JFJonathan Fridell
Jonathan Fridell
ACArianna Cabrales
Arianna Cabrales
TNTejas Nikumbh
Tejas Nikumbh
RMRichard Mangus
Richard Mangus

6 August 2022 in American Journal of Case Reports
Verified
Journal Article
Open access
PMPlamen Mihaylov
Plamen Mihaylov
ALAndrew J. Lutz
Andrew J. Lutz
FOFederico Oppliger
Federico Oppliger
JLJingmei Lin
Jingmei Lin
Unusual clinical course Human adenovirus is a well-known pathogen that can potentially lead to severe infection in immunocompromised patients. Adenovirus infections in solid-organ transplant recipients can range from asymptomatic to severe, prolonged, disseminated disease, and have a significant impact on morbidity, mortality, and graft survival. The clinical manifestations vary from asymptomatic and flu-like illness to severe life-threatening viremia with multi-organ failure. Post-transplant adenovirus infection is well described in kidney recipients, but in adult liver transplant recipients the impact of the virus is not well described. In this report, a case of disseminated adenovirus infection with subsequent fatal acute liver failure in a post-kidney transplant patient is presented. A 51-year-old man underwent a deceased kidney transplantation for focal segmental glomerulosclerosis. Shortly after the kidney transplantation, he received multiple plasmapheresis with additional steroid treatments for cellular rejection and reoccurrence of his primary kidney disease. Three weeks after the kidney transplant, he developed a disseminated adenovirus infection with subsequent acute liver failure. Despite the early diagnosis and aggressive treatment, the patient died. Patients with organ transplantation with autoimmune background etiology are usually over-immunosuppressed to avoid early rejection. In this population, opportunistic infections are not rare. Fever, general malaise, and transplant organ dysfunction are the first signs of bacterial or viral infection. Early infectious diseases work-up, including tissue biopsy, is fundamental to establish a diagnosis. Broad antibiotic and possible antiviral aggressive treatment are mandatory.

14 July 2016 in American Journal of Nephrology
Verified
Journal Article
Open access
BEBurcin Ekser
Burcin Ekser
RMRichard S. Mangus
Richard S. Mangus
CKChandrashekhar A Kubal
Chandrashekhar A Kubal
JFJonathan A. Fridell
Jonathan A. Fridell
JPJohn A. Powelson
John A. Powelson
WGWilliam C. Goggins
William C. Goggins
Background: Enteric hyperoxaluria (EH) occurs with a rate of 5-24% in patients with inflammatory bowel disease, ileal resection and modern bariatric surgery. The excessive absorption of calcium oxalate causes chronic kidney disease (CKD) in patients with EH. In the literature, a single experience was reported in combined intestine-kidney transplantation (CIKTx) in patients with CKD due to EH. Methods: After a report of 2 successful cases of CIKTx in patients with EH and CKD, one was performed at our center in a 59-year-old Caucasian female who developed intestinal failure with total parenteral nutrition (TPN) dependence after a complication post-bariatric surgery. Before CIKTx, she underwent kidney transplantation alone (KTA) twice, which failed due to oxalate nephropathy. Results: In July 2014, the patient underwent CIKTx and bilateral allograft nephrectomy to avoid EH and oxalate stone burden. The postoperative course was complicated with acute tubular necrosis due to the use of high pressors related to perioperative bleeding. The patient was discharged 79 days after CIKTx with a serum creatinine (sCr) of 1.2 mg/dl and free of TPN. Her sCr increased at 7 months and a renal biopsy showed oxalate nephropathy. SLC26A6 (oxalate transporter) staining was significantly diminished in native duodenum/rectum as well as in intestinal allograft compared to control. Conclusions: KTA in patients with CKD secondary to EH should not be recommended due to high risk of recurrence. Although other centers showed good long-term outcomes in CIKTx, our patient experienced recurrence of EH due to oxalate transporter defect, early kidney allograft dysfunction and prolonged antibiotic use.